President & CEO, BPGbio

Dr. Niven R. Narain is President & CEO of BPGbio. Dr. Narain was previously the Co-Founder, President & CEO of BERG which was acquired by BPGbio. He has been recognized as a pioneer in technology development at the intersection of Biology and AI and is inventor of the Interrogative Biology® platform. Under his leadership, actionable disease insight has fueled a deep pipeline of assets subject of over 650 issued and pending US and international patents. He is an industry thought leader in precision medicine, drug development, and AI/ML serving as a frequent speaker at Economist, Bloomberg, Financial Times, Wired, and Aspen Ideas in addition to many international meetings on medicine and technology. Niven is a member of the NASA/Gene Lab Steering Committee, Advisor to US DoD leadership on breast and prostate cancer, R&D Committee Chairman for the School of Applied Computational Sciences at Meharry Medical College and forged strategic partners with industry, academia, and US and UK governments. He also serves on the Healthy Aging Initiative Commission at No. 10.  He has been featured on CNN, BBC, CNBC, FORBES, Fox Business, NYT, and the WSJ, among others. Niven is most passionate about improving patient care and enabling increased access to innovative medicines towards improved healthcare outcomes.